Laigo Bio: Funding, Investors & Team (Oct 2026)
Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.
Laigo Bio has raised $6.4M across 1 funding round on record, the most recent a Seed of $6.4M announced in Mar 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Laigo Bio Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Laigo Bio Funding Rounds
Laigo Bio Founders and Leadership Team
Contact details for the Laigo Bio team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Laigo Bio Funding Compared to Other Biotechnology Startups
Laigo Bio's latest round of $6.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Laigo Bio in Biotechnology and Utrecht
Companies Similar to Laigo Bio
ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients…
uniQure is a leader in the field of gene therapy and had developed the first and currently the only gene…
Vertoro transforms woody and agricultural residues into a wide range of bio-based chemicals, materials, and…
Vivici is a B2B ingredients firm that provides nutritious and sustainable animal-free dairy proteins…
New Dawn Bio is a biotechnology research firm that specializes in wood production.
Triple Bio is a biotech startup focused on improving productivity and sustainability in dairy and beef…
ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the…
Detact holds the patent for a new, innovative, real-time, bacterial detection system that enables hospital…
BioLinker is a creation of manufactured science, protein blend packs, and protein.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
Laigo Bio Funding FAQs
What does Laigo Bio do?
Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.
How much funding has Laigo Bio raised?
Laigo Bio has raised $6.4M across 1 round on record. The most recent is a Seed of $6.4M announced in Mar 2026.
When did Laigo Bio last raise funding?
Laigo Bio's most recent funding round on record is a Seed of $6.4M, announced in Mar 2026.
Who founded Laigo Bio?
FundedIQ lists Matthew Baker (Founder) at Laigo Bio.
Where is Laigo Bio headquartered?
Laigo Bio is based in Utrecht, Utrecht, The Netherlands.
How many employees does Laigo Bio have?
Laigo Bio is in the 11-50 employee band.
How does Laigo Bio's funding compare to other Biotechnology startups?
Laigo Bio's latest round of $6.4M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Laigo Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Laigo Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.